Lixte Biotechnology Holdings Inc (LIXT)

Precedente Chiudi:

$3.14

Aprire:

$3.2

Volume 24 ore:

18,682

Capitalizzazione di mercato:

$7.33M

Reddito:

-

Utile/perdita netta:

$-5.09M

Rapporto P/E:

-0.7459

EPS:

-3.7

Flusso di cassa netto:

$-4.29M

1 W Prestazione:

-14.29%

1M Prestazione:

-18.34%

6M Prestazione:

+11.29%

1 anno Prestazione:

+391.98%

Intervallo 1D:

$2.76

$3.257

Portata 52W:

$0.472

$9.50

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Nome

Lixte Biotechnology Holdings Inc

Settore

Healthcare (1191)

Industria

Biotechnology (687)

Telefono

631 830 7092

Indirizzo

680 East Colorado Boulevard, Suite 180, Pasadena

Dipendente

3

Cinguettio

Prossima data di guadagno

2024-05-08

Ultimi documenti SEC

LIXT's Discussions on Twitter

Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie

Gold Moves Higher; Velo3D Shares Plummet

Benzinga

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Crude Oil Edges Lower; PaySign Shares Spike Higher

Benzinga

Dow Jumps Over 200 Points; UniFirst Posts Downbeat Earnings

Benzinga

LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments

GlobeNewswire Inc.

LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI

GlobeNewswire Inc.

Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari

Lixte Biotechnology Holdings Inc (LIXT) Reddito netto 2024

Lixte Biotechnology Holdings Inc (LIXT) Flusso di cassa 2024

Lixte Biotechnology Holdings Inc (LIXT) Utile per azione 2024